In these settings, when anti-PD-1 was given together with RT, superior tumor growth inhibition of primary and secondary (non-irradiated) tumors and overall survival were observed, compared to RT or anti-PD-L1 given alone. This evidence concerns the gene CD274 and neoplasm.